Blog
RSS FeedPosted by Michael Wonder on 25 Sep 2023
ICER finalises 2023 updates to value assessment framework
25 September 2023 - Updates to methods and public meeting procedures reflect experience with previous framework, benchmarking with other HTA groups, ...
Posted by Michael Wonder on 07 Feb 2022
Why so few value assessments on health services and procedures, and what should be done?
4 February 2022 - The field of cost effectiveness analysis has grown rapidly but in somewhat lopsided fashion. ...
Posted by Michael Wonder on 24 Sep 2020
ICER releases draft evidence report on supervised injection facilities
24 September 2020 - Public comment period now open until 22 October 2020; requests to make oral comment during public ...
Posted by Michael Wonder on 20 May 2020
ICER posts draft scoping document for the assessment of supervised injection facilities
19 May 2020 - Document open to public comment until 9 June 2020. ...
Posted by Michael Wonder on 13 Nov 2019
ICER seeks public input to guide selection of non-drug assessment topics for 2020
13 December 2019 - Suggestions for new topics and comments on initial list of potential topics are encouraged; input most helpful ...
Posted by Michael Wonder on 04 Oct 2017
Institute for Clinical and Economic Review Evidence Report finds cognitive and mind-body therapies for treatment of back pain provide added benefit at reasonable cost
4 October 2017 - More evidence needed to distinguish between therapies and to fully understand their effects in chronic neck pain. ...
Posted by Michael Wonder on 11 Apr 2017
ICER posts draft scoping document on cognitive and mind-body interventions to treat chronic low back and neck pain
10 April 2017 - Report expected to review evidence on acupuncture, cognitive behavioural therapy, mindfulness, yoga, and tai chi; scoping document ...
Posted by Michael Wonder on 20 Mar 2017
Institute for Clinical and Economic Review to review certain non-pharmacologic interventions for chronic low back and neck pain in upcoming review
20 March 2017 - The Institute for Clinical and Economic Review will develop a report assessing the comparative clinical effectiveness ...